How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Mongabay News on MSN
On Indonesia’s longest river, a Borneo community passes crucial public health milestone
Children’s laughter skimmed over water the color of mud as mothers wrung laundry over banks where the Sekadau joins the ...
Pete Rathburn is a copy editor and fact-checker with expertise in economics and personal finance and over twenty years of experience in the classroom. Getty Images, Maskot Law is a big, service-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback